BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33317583)

  • 1. Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells.
    McDonald WS; Miyamoto K; Rivera R; Kennedy G; Almeida BSV; Kingsbury MA; Chun J
    Mol Brain; 2020 Dec; 13(1):169. PubMed ID: 33317583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of LPA1 signaling results in defective cortical development.
    Estivill-Torrús G; Llebrez-Zayas P; Matas-Rico E; Santín L; Pedraza C; De Diego I; Del Arco I; Fernández-Llebrez P; Chun J; De Fonseca FR
    Cereb Cortex; 2008 Apr; 18(4):938-50. PubMed ID: 17656621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis.
    Dubin AE; Herr DR; Chun J
    J Neurosci; 2010 May; 30(21):7300-9. PubMed ID: 20505096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesis.
    Hu HB; Song ZQ; Song GP; Li S; Tu HQ; Wu M; Zhang YC; Yuan JF; Li TT; Li PY; Xu YL; Shen XL; Han QY; Li AL; Zhou T; Chun J; Zhang XM; Li HY
    Nat Commun; 2021 Jan; 12(1):662. PubMed ID: 33510165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling.
    Herr KJ; Herr DR; Lee CW; Noguchi K; Chun J
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15444-9. PubMed ID: 21878565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding.
    Kingsbury MA; Rehen SK; Contos JJ; Higgins CM; Chun J
    Nat Neurosci; 2003 Dec; 6(12):1292-9. PubMed ID: 14625558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
    Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R
    J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation.
    Spohr TC; Choi JW; Gardell SE; Herr DR; Rehen SK; Gomes FC; Chun J
    J Biol Chem; 2008 Mar; 283(12):7470-9. PubMed ID: 18198181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and cell biology of lysophosphatidic acid receptor-mediated signaling during cortical neurogenesis.
    Kingsbury MA; Rehen SK; Ye X; Chun J
    J Cell Biochem; 2004 Aug; 92(5):1004-12. PubMed ID: 15258921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex.
    Hecht JH; Weiner JA; Post SR; Chun J
    J Cell Biol; 1996 Nov; 135(4):1071-83. PubMed ID: 8922387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.
    González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R
    J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia.
    Plastira I; Bernhart E; Joshi L; Koyani CN; Strohmaier H; Reicher H; Malle E; Sattler W
    J Neuroinflammation; 2020 Apr; 17(1):127. PubMed ID: 32326963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice.
    López-Serrano C; Santos-Nogueira E; Francos-Quijorna I; Coll-Miró M; Chun J; López-Vales R
    Brain Behav Immun; 2019 Feb; 76():258-267. PubMed ID: 30550929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid (LPA) signaling via LPA
    Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype.
    Plastira I; Bernhart E; Goeritzer M; DeVaney T; Reicher H; Hammer A; Lohberger B; Wintersperger A; Zucol B; Graier WF; Kratky D; Malle E; Sattler W
    J Neuroinflammation; 2017 Dec; 14(1):253. PubMed ID: 29258556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of in utero electroporation of G-protein coupled receptor (GPCR) genes, for subcellular localization of hardly identifiable GPCR in mouse cerebral cortex.
    Kim NH; Kim S; Hong JS; Jeon SH; Huh SO
    Mol Cells; 2014 Jul; 37(7):554-61. PubMed ID: 25078448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A blocking peptide stabilizes lysophosphatidic acid receptor 1 and promotes lysophosphatidic acid-induced cellular responses.
    Taleb SJ; Wei J; Mialki RK; Dong S; Li Y; Zhao J; Zhao Y
    J Cell Biochem; 2021 Aug; 122(8):827-834. PubMed ID: 33847006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy.
    Simo KA; Niemeyer DJ; Hanna EM; Swet JH; Thompson KJ; Sindram D; Iannitti DA; Eheim AL; Sokolov E; Zuckerman V; McKillop IH
    HPB (Oxford); 2014 Jun; 16(6):534-42. PubMed ID: 24750398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
    Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.